GSK Investigational Site — Nashville, Tennessee

Which of these are you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of GSK Investigational Site, compiled from the ClinicalTrials.gov public registry.

178

Registered studies

Active

Recruiting now

142

Completed

Stopped or withdrawn

Most-studied conditions

Neoplasms · Multiple Myeloma · Lung Cancer, Non-Small Cell · Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera…

Recently updated registry entries

NCT05996471 — A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir… (Active Not Recruiting)
NCT05334368 — Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial (Recruiting)
NCT07227311 — A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With… (Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.